Chapter: 1 INTRODUCTION

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing incidences of cardiac disorders
3.4.1.2. Technological advancements
3.4.1.3. Increasing patient awareness
3.4.1.4. Presence of high-unmet medical needs

3.4.2. Restraints

3.4.2.1. Limited insurance coverage and high cost of devices
3.4.2.2. Preference for drugs

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities in emerging economies
3.4.3.2. Development of new MRI-labeled devices

Chapter: 4 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ELECTROCARDIOGRAM (ECG) DEVICES

4.2.1. By type

4.2.1.1. Resting ECG devices
4.2.1.2. Stress ECG devices
4.2.1.3. ECG Holter monitors

4.2.1.3.1. Wired Holter monitors
4.2.1.3.2. Wireless Holter monitors

4.2.2. By lead type

4.2.2.1. Single lead
4.2.2.2. 3-6 lead
4.2.2.3. 12-lead

4.2.3. Key market trends
4.2.4. Key growth factors and opportunities
4.2.5. Market size and forecast

4.3. IMPLANTABLE LOOP RECORDER (ILR)

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. CARDIAC OUTPUT MONITORING DEVICES (COM)

4.4.1. Minimally invasive COM devices
4.4.2. Non-invasive COM devices
4.4.3. Key market trends
4.4.4. Key growth factors and opportunities
4.4.5. Market size and forecast

4.5. EVENT MONITORS

4.5.1. By type

4.5.1.1. Pre-symptom
4.5.1.2. Post-symptom

4.5.2. By technology

4.5.2.1. Manual event monitors
4.5.2.2. Autodetect monitors

4.5.3. Key market trends
4.5.4. Key growth factors and opportunities
4.5.5. Market size and forecast

4.6. PACEMAKERS

4.6.1. Implantable pacemakers
4.6.2. External pacemakers
4.6.3. Key market trends
4.6.4. Key growth factors and opportunities
4.6.5. Market size and forecast

4.7. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES

4.7.1. CRT-P (CRT with pacemaker function)
4.7.2. CRT-D (CRT with pacemaker and ICD function)
4.7.3. Key market trends
4.7.4. Key growth factors and opportunities
4.7.5. Market size and forecast

4.8. DEFIBRILLATORS

4.8.1. Implantable cardioverter defibrillators (ICDs)

4.8.1.1. Transvenous implantable cardioverter defibrillator (T-ICDs)

4.8.1.1.1. Single-chamber ICDs
4.8.1.1.2. Dual-chamber ICDs

4.8.1.2. Subcutaneous implantable cardioverter defibrillator (S-ICDs)

4.8.2. External defibrillator

4.8.2.1. Manual external defibrillator
4.8.2.2. Automated external defibrillator (AEDs)

4.8.2.2.1. Semi-automated external defibrillator
4.8.2.2.2. Fully automated external defibrillator

4.8.2.3. Wearable cardioverter defibrillator (WCDs)

4.8.3. Key market trends
4.8.4. Key growth factors and opportunities
4.8.5. Market size and forecast

4.9. VENTRICULAR ASSIST DEVICES (VADS)

4.9.1. Left ventricular assist device (LVAD)
4.9.2. Right ventricular assist device (RVAD)
4.9.3. Biventricular assist device (BIVAD)
4.9.4. Key market trends
4.9.5. Key growth factors and opportunities
4.9.6. Market size and forecast

Chapter: 5 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS & CLINICS

5.2.1. Market size and forecast

5.3. HOME SETTINGS

5.3.1. Market size and forecast

5.4. AMBULATORY SURGICAL CENTERS (ASCS)

5.4.1. Market size and forecast

Chapter: 6 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany
6.3.5. France
6.3.6. UK
6.3.7. Italy
6.3.8. Spain
6.3.9. Switzerland
6.3.10. Rest of Europe

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. India
6.4.7. Malaysia
6.4.8. Australia
6.4.9. New Zealand
6.4.10. Rest of Asia-Pacific

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. South Africa
6.5.6. Egypt
6.5.7. Rest of LAMEA

Chapter: 7 COMPANY PROFILES

7.1. ABIOMED, INC.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves & developments

7.2. BERLIN HEART GMBH

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Key strategic moves & developments

7.3. BIOTRONIK SE & CO. KG

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Key strategic moves & developments

7.4. BOSTON SCIENTIFIC CORPORATION

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves & developments

7.5. CARDIAC SCIENCE CORPORATION

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Key strategic moves and developments

7.6. GENERAL ELECTRIC COMPANY

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves & developments

7.7. HILL-ROM HOLDINGS, INC.

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves & developments

7.8. JARVIK HEART, INC.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Key strategic moves & developments

7.9. KONINKLIJKE PHILIPS N.V.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves & developments

7.10. LIVANOVA PLC

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves & developments

7.11. MEDTRONIC PLC

7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Business performance
7.11.5. Key strategic moves & developments

7.12. NIHON KOHDEN CORPORATION

7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Business performance
7.12.5. Key strategic moves and developments

7.13. RELIANTHEART, INC.

7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segments
7.13.4. Key strategic moves & developments

7.14. SCHILLER AG

7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Key strategic moves & developments

7.15. ST. JUDE MEDICAL, INC.

7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Operating business segments
7.15.4. Business performance
7.15.5. Key strategic moves & developments